<DOC>
	<DOCNO>NCT01855815</DOCNO>
	<brief_summary>The purpose Hemolung RAS Registry Program collect retrospective , de-identified , standard care data follow commercial use Hemolung RAS .</brief_summary>
	<brief_title>Hemolung RAS Registry Program</brief_title>
	<detailed_description>ALung 's post-market Hemolung RAS Registry Program provide continuum measure Hemolung RAS effectiveness safety real-world set beyond result report pre-market clinical feasibility study . The Hemolung RAS Registry Program part ALung 's 1 ) evaluation clinical evidence throughout life cycle product , 2 ) long term residual risk assessment product , 3 ) commitment maintain quality system integrate continuous quality improvement product . On voluntary basis , participate physician institutional staff enter de-identified data online secure , password protect , regulatory-compliant Hemolung RAS Registry Portal retrospective manner follow patient 's ICU discharge , status 28 day post-Hemolung therapy , death whichever earlier . There requirement collect report data outside standard care . The program 's methodology , data monitoring statistical analysis plan consistent type initiative real-world setting .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Hypercapnia</mesh_term>
	<criteria />
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>